GeekWire

AUGUST 12, 2024

To make a profit, yes, but also to support the development of technologies needed to sustain settlements on the Red Planet. ” The XPRIZE Foundation specializes in this kind of prize program, but the Mars Society has done prizes as well, albeit on a smaller scale. Its long-term goal?

Biotechnology 123

Biotechnology Chemicals Artificial Intelligence Engineering 123

CIO Business Intelligence

JUNE 22, 2023

While Silicon Valley still pays top dollar for IT pros, the war for talent has moved beyond the technology industry, with other verticals vying for talented IT workers who have the skills to enable digital transformation, process improvement, change management, and the development of apps and services.

Industry 306

Industry Project Management Quality Assurance Insurance 306

GeekWire

JUNE 30, 2021

based company developing technologies to accelerate the process of drug discovery, announced today that it plans to go public via an IPO. Absci aims to circumvent current processes for developing protein-based drugs, which often require manufacture in mammalian cells, a cumbersome and difficult method. Absci Photo).

Company 130

Company Biotechnology .Net Programming 130

CIO Business Intelligence

DECEMBER 10, 2024

Where quantum development is, and is heading In the meantime, the United Nations designation recognizes that the current state of quantum science has reached the point where the promise of quantum technology is moving out of the experimental phase and into the realm of practical applications.

Artificial Intelligence 246

Artificial Intelligence Research IBM Industry 246

GeekWire

APRIL 15, 2021

Chad Robins, left, is co-founder and CEO of Adaptive Biotechnologies, which he co-founded with his brother, Harlan Robins, right, a theoretical physicist turned computational biologist who is the company’s chief scientific officer. Adaptive Biotechnologies Photo). Lance Solomon.

Biotechnology 107

Biotechnology Education Web Services Insurance 107

GeekWire

SEPTEMBER 14, 2020

based biotechnology company struck a deal with Merck in which the pharmaceutical powerhouse will provide a $600 million upfront payment and make a $1 billion equity investment to continue development of treatments for breast cancer. billion if development milestones are met, and another $1.75

Biotechnology 106

Biotechnology Pharmaceuticals Journal Licensing 106

GeekWire

FEBRUARY 11, 2021

The company is built on technology developed over two decades by Seattle researchers Dr. Hans-Peter Kiem of the Fred Hutchinson Cancer Research Center and Dr. André Lieber of the University of Washington School of Medicine. (Fred Hutch Photo). In 2019, Kiem gave a TEDxSeattle talk on the science involved.

Biotechnology 139

Biotechnology Research Healthcare Engineering 139

GeekWire

FEBRUARY 17, 2021

Notch Therapeutics is commercializing technologies developed in the labs of Juan-Carlos Zúñiga-Pflücker, left, chair of Notch’s scientific advisory board, and Chief Scientific Officer Peter Zandstra. The biotech company was founded in 2018 and is developing stem cell-derived immunotherapies for cancer. Notch Photo).

Biotechnology 120

Biotechnology Pharmaceuticals Research Development 120

GeekWire

OCTOBER 14, 2021

Seattle-based cell therapy startup Immusoft will collaborate with pharma giant Takeda to develop treatments targeted to the central nervous system in a deal worth potentially more than $900 million. Immusoft’s most advanced therapeutic program is designed to treat a rare enzyme deficiency disorder, Hurler syndrome. Immusoft Photo).

Biotechnology 122

Biotechnology Licensing Programming Engineering 122

GeekWire

JULY 8, 2021

Absci, which partners with other biopharma companies to identify and develop protein-based drug candidates, has its roots in Portland. Things are different now, said Alexandre, as companies such as Seagen and Adaptive Biotechnologies go public and grow in the region. Bolstering the workforce, increasing regional connections.

Biotechnology 130

Biotechnology Industry Real Estate Company 130

GeekWire

JULY 19, 2021

Eliem has two lead drug candidates in development: ETX-810 for chronic pain conditions and ETX-155 for mood disorders and epilepsy. In June, Seattle-based Nautilus Biotechnology, led by Isilon Systems co-founder Sujal Patel, went public via a SPAC merger. It aims to raise up to $80 million with the IPO. Eliem’s tech.

Biotechnology 110

Biotechnology Pharmaceuticals Groups Development 110

GeekWire

JANUARY 9, 2023

In Washington state, Absci , Zymeworks , TwinStrand Biosciences , NanoString Technologies , Neoleukin Therapeutics and Sana Biotechnology all shed employees in 2022. Century launched in 2019 to develop therapies from induced pluripotent stem cells (iPSCs), which can be derived from adult tissue, and pulled in $242.7

Biotechnology 117

Biotechnology Programming Company Development 117

CTOvision

FEBRUARY 10, 2016

The technology was developed under DARPA’s Reliable Neural-Interface Technology (RE-NET) program , and offers new potential for safely expanding the use of brain-machine interfaces (BMIs) to treat physical disabilities and neurological disorders.

.Net 150

.Net Biotechnology Study Research 150

GeekWire

APRIL 18, 2023

The category highlights pioneering health, life science, biotechnology or medical breakthroughs that hold great promise for bettering our lives or improving the healthcare system. Good Therapeutics Graphic) Developing therapeutics that are active only where they are needed in the body has the potential to reduce toxic side effects.

Biotechnology 122

Biotechnology Healthcare Development Software 122

GeekWire

MARCH 9, 2023

The November layoffs coincided with a decision by Neoleukin to discontinue development of a computationally designed protein therapeutic being tested in a phase 1 trial. Neoleukin shifted its focus to developing other protein therapeutics. Neoleukin currently has 46 employees, according to a spokesperson, down from 77 in September.

Biotechnology 120

Biotechnology Licensing Programming Banking 120

GeekWire

OCTOBER 9, 2024

Phase Genomics has developed technology for sequencing DNA from wide-ranging and tricky to study organisms. Other former positions include leadership roles at the Gates Foundation and directing the global drug development program at PATH. Susan Wyrick of Sana Biotechnology.

Biotechnology 114

Biotechnology Microsoft Dell Education 114

GeekWire

APRIL 12, 2023

Workplace of the Year finalists, clockwise from top left: Adaptive Biotechnologies co-founders Harlan and Chad Robins; the Helion team; Impinj offices in Seattle; Treasury4 team; Blink CEO Karen Clark Cole. This year’s finalists are Adaptive Biotechnologies, Blink, Helion, Impinj and Treasury4. Blink Blink CEO Karen Clark Cole.

Biotechnology 98

Biotechnology Policies Meeting Energy 98

GeekWire

MAY 20, 2021

The program will start in November at the UW. (UW It will host a 9-month program this November for 20-to-25 companies in partnership with Microsoft and the University of Washington’s business, engineering, and computer science schools. “This is the track,” Dooley said.

Microsoft 115

Microsoft Biotechnology Healthcare Programming 115

GeekWire

OCTOBER 20, 2020

Thielke is currently managing director of Hines Asia Pacific, a global real estate investment, development and management firms. Moore previously held senior human resources roles at Mercedes-Benz’s research and development subsidiary, Apple and Samsung Electronics. Nautilus Biotechnology Photo). Nick Nelson. WTIA Photo).

Fractional CTO 108

Fractional CTO CTO Biotechnology CTO Hire 108

GeekWire

JANUARY 14, 2021

AltPep is developing tools and treatments for diseases caused by amyloid proteins that are incorrectly folded and create harmful deposits. AltPrep is currently focused on Alzheimer’s and developing tools that can detect the illness even before someone is symptomatic. Athira went public last year.

Real Estate 111

Real Estate Biotechnology Pharmaceuticals Licensing 111

GeekWire

DECEMBER 27, 2022

He’s now CEO of Nautilus Biotechnology, and he’s not taking any big chances in the current economic downturn. “As a development stage company, we’re doing everything we can to strike the right balance between accelerating the development of our platform while seeking to extend our cash runway,” said Patel.

Industry 115

Industry Biotechnology CTO Company 115

GeekWire

MAY 19, 2023

GeekWire Photo / Kevin Lisota) The gist: The Seattle startup is developing all electric powerboats for the retail market. Deal of the Year, presented by Wilson Sonsini Winner: Bungie Warren Rice, director of business development at Bungie, accepts the award for Deal of the Year at the 2023 GeekWire Awards. billion deal. billion deal.

Biotechnology 143

Biotechnology Microsoft Education Engineering 143

GeekWire

JULY 27, 2021

Alexandre believes there is more work for companies and organizations such as Life Science Washington to do in support of the industry, especially when it comes to talent development. Her work included developing health policy in Washington D.C., Born in Vancouver, Wash.,

Biotechnology 120

Biotechnology SAP Media Healthcare 120

GeekWire

JANUARY 12, 2022

He develops tools to help understand massive-scale genomic and biomedical data and has helped generate online learning programs that have enrolled more than 8 million people. And so we started to conceive how could we build a program that would bring people from the community into the data enterprise at Hopkins.

Data 144

Data Nonprofit Research Training 144

GeekWire

JULY 15, 2021

Seattle is known for its strength in cell therapy, notes Modulus chief scientist Max Darnell , with growing biotech companies such as Sana Biotechnology and Lyell Immunopharma, as well as an arm of Bristol Myers Squib. “We want to be this discovery player that can plug into these larger incumbents,” he said.

Biotechnology 122

Biotechnology Artificial Intelligence Research Groups 122

GeekWire

JUNE 29, 2021

” The company, in clinical-stage development of a compound for Alzheimer’s and Parkinson’s disease dementia, raised about $204 million in the IPO, at a share price of $17.00. The lawsuits maintain that Kawas’ graduate research laid the groundwork for Athira’s efforts to develop new treatments. on Tuesday.

Biotechnology 112

Biotechnology Research Study Development 112

GeekWire

MARCH 10, 2023

The news is a bright spot for Seattle’s biopharma scene which has seen employee cuts at several biotech companies recently as part of wider layoffs in the industry, including at NanoString Technologies , Sana Biotechnology , Eliem Therapeutics and Neoleukin Therapeutics. The company invested $1.2 billion this year. It reported $19.3

Artificial Intelligence 98

Artificial Intelligence Biotechnology CTO Web Services 98

GeekWire

NOVEMBER 11, 2020

. — Microsoft added to its senior leadership team with the appointment of Christopher Young as executive vice president of business development. Young will be responsible for developing Microsoft’s global business development strategies, including assessing partnerships, alliances, venture investments, and joint ventures.

CTO Hire 110

CTO Hire Real Estate Insurance Microsoft 110

GeekWire

DECEMBER 13, 2023

LinkedIn Photo) Editor’s note: William Canestaro is managing director at Seattle venture capital firm WRF Capital and leads the biotechnology investment team. Seagen has a huge pipeline for early programs and is undisputedly the anchor tenant in Pacific Northwest biotech. William Canestaro. He worked to grow the Bothell, Wash.

Biotechnology 104

Biotechnology Programming Company Development 104

GeekWire

JULY 13, 2021

In addition, Fred Hutchinson Cancer Center would oversee the clinical oncology programs at both the center and UW Medical Center, according to a press release. Scientists there are developing ways to detect some cancers early by analyzing blood samples — research that can be brought more swiftly to the clinic under the new arrangement.

Research 104

Research Biotechnology Programming Examples 104

GeekWire

AUGUST 27, 2024

Sana Photo) — Dhaval Patel joined Sana Biotechnology as executive vice president and chief scientific officer. Aaron Bilyeu joined Cloverleaf Infrastructure as its chief development officer. Bilyeu previously worked for Meta as the senior director of site development for its data centers worldwide. The company is ranked No.

CTO Hire 107

CTO Hire Energy Data Center Biotechnology 107

GeekWire

JUNE 18, 2021

Montoya is responsible for Equinix’s global cybersecurity risk program. Seattle-based Nautilus Biotechnology appointed Human Protein Atlas Director Emma Lundberg to its scientific advisory board. Nautilus is developing a new way to analyze the proteome, the set of proteins in a biological sample.

Energy 117

Energy Biotechnology Real Estate Transportation 117

SecureWorld News

SEPTEMBER 29, 2021

The Quad launched "Quad Principles on Technology Design, Development, Governance, and Use" in the hopes that these "universal values" will promote competition and innovation when it comes to making technological advancements. This includes building security in rather than bolting it on. "We

Healthcare 97

Healthcare Biotechnology Trends Government 97

SecureWorld News

MARCH 9, 2023

North Korea's cyber program poses a sophisticated and agile espionage, cybercrime, and attack threat. New technologies—particularly in the fields of AI and biotechnology—are being developed and are proliferating faster than companies and governments can shape norms, protect privacy, and prevent dangerous outcomes. interests.

Biotechnology 97

Biotechnology Government Malware Network 97

GeekWire

JULY 24, 2020

In 2007, he co-founded Chronus , a company that built digital tools for employee development programs. Itucas continues to lead product and operations at the startup, which participated in the 2018 Techstars Seattle accelerator program. .” Vellore came up with the idea for Ally after an experience at his previous startup.

Virtualization 145

Virtualization Research Programming Biotechnology 145

GeekWire

MAY 20, 2021

How we can help companies do the best with internal and external talent — to develop, to hire, to retain, to redeploy. Stephanie Strong is the founder and CEO of Boulder Care, an app-based addiction treatment program for those suffering from opioid use disorder. Other finalists: Accolade; Athira Pharma; Rover; and Sana Biotechnology.

CTO Hire 138

CTO Hire Biotechnology Education Groups 138

GeekWire

OCTOBER 15, 2020

The round is one of the largest for a Seattle-area startup this year and the latest in a string of recent $100 million-plus investments in companies such as Qumulo, Auth0, Sana Biotechnology, and others. The FCC in April approved a $200 million program to fund telehealth services and devices. And people keep coming back to 98point6.

Virtualization 142

Virtualization Healthcare Insurance Biotechnology 142